Oncolytic Viruses for Tumor Precision Imaging and Radiotherapy.
Sign Up to like & getrecommendations! Published in 2018 at "Human gene therapy"
DOI: 10.1089/hum.2017.189
Abstract: In 2003 in China, Peng et al. invented the recombinant adenovirus expressing p53 (Gendicine) for clinical tumor virotherapy. This was the first clinically approved gene therapy and tumor virotherapy drug in the world. An oncolytic… read more here.
Keywords: tumor precision; imaging radiotherapy; oncolytic viruses;